Current issue
Archive
Manuscripts accepted
About the Journal
Editorial office
Editorial board
Abstracting and indexing
Subscription
Contact
Ethical standards and procedures
Most read articles
Instructions for authors
Article Processing Charge (APC)
Regulations of paying article processing charge (APC)
CLINICAL RESEARCH
Relationships between blood concentrations of cadmium, lead, mercury, selenium, and manganese and the risk of chronic kidney disease: a cross-sectional study based on NHANES 2011–2018
1
Department of Nephrology, Yuyao People’s Hospital, Ningbo, China
2
Department of Geriatrics, Yuyao People’s Hospital, Ningbo, China
Submission date: 2023-12-03
Final revision date: 2024-01-09
Acceptance date: 2024-01-16
Online publication date: 2024-12-13
KEYWORDS
TOPICS
ABSTRACT
Introduction:
Currently, knowledge on relationships between blood concen-trations of cadmium, lead, mercury, selenium, and manganese and the risk of chronic kidney disease (CKD) is lacking. The aim of the study was to ex-plore the relationships between blood concentrations of heavy metals and the occurrence of CKD.
Material and methods:
Data from the National Health and Nutrition Examination Survey (NHANES) 2011–2018 were used to investigate the relationships between blood concentrations of mercury, lead, cadmium, selenium, and manganese and the occurrence of CKD using a weighted logistic recession analysis. Restrictive cubic spline analysis was applied to assess the dose–response relationship. The sample population was divided into four groups based on the quartiles of heavy metal concentrations (Q1: < 25th percentile, Q2: 25th–50th percentile, Q3: 50th–75th percentile, Q4: ≥ 75th percentile).
Results:
A total of 15,450 participants were included. With regard to blood lead concentrations, the odds ratio (OR) for CKD in Q4 relative to Q1 was 1.36 (95% confidence interval [CI]: 1.20–1.61), indicating an increased oc-currence of CKD in Q4. With regard to blood cadmium concentrations, the ORs for CKD in Q2, Q3, and Q4 were 1.06 (95% CI: 0.92–1.22), 1.21 (95% CI: 1.05–1.39), and 1.52 (95% CI: 1.31–1.76), respectively. Non-linear dose–response relationships were identified between blood cadmium and lead concentrations and the occurrence of CKD. Further, blood lead and cadmium concentrations showed statistically significant interaction effects with age, hypertension, and obesity on CKD.
Conclusions:
Higher cadmium and lead concentrations in blood are asso-ciated with increased occurrence of CKD, especially in older adults, people with hypertension, and people with obesity.
Currently, knowledge on relationships between blood concen-trations of cadmium, lead, mercury, selenium, and manganese and the risk of chronic kidney disease (CKD) is lacking. The aim of the study was to ex-plore the relationships between blood concentrations of heavy metals and the occurrence of CKD.
Material and methods:
Data from the National Health and Nutrition Examination Survey (NHANES) 2011–2018 were used to investigate the relationships between blood concentrations of mercury, lead, cadmium, selenium, and manganese and the occurrence of CKD using a weighted logistic recession analysis. Restrictive cubic spline analysis was applied to assess the dose–response relationship. The sample population was divided into four groups based on the quartiles of heavy metal concentrations (Q1: < 25th percentile, Q2: 25th–50th percentile, Q3: 50th–75th percentile, Q4: ≥ 75th percentile).
Results:
A total of 15,450 participants were included. With regard to blood lead concentrations, the odds ratio (OR) for CKD in Q4 relative to Q1 was 1.36 (95% confidence interval [CI]: 1.20–1.61), indicating an increased oc-currence of CKD in Q4. With regard to blood cadmium concentrations, the ORs for CKD in Q2, Q3, and Q4 were 1.06 (95% CI: 0.92–1.22), 1.21 (95% CI: 1.05–1.39), and 1.52 (95% CI: 1.31–1.76), respectively. Non-linear dose–response relationships were identified between blood cadmium and lead concentrations and the occurrence of CKD. Further, blood lead and cadmium concentrations showed statistically significant interaction effects with age, hypertension, and obesity on CKD.
Conclusions:
Higher cadmium and lead concentrations in blood are asso-ciated with increased occurrence of CKD, especially in older adults, people with hypertension, and people with obesity.
REFERENCES (38)
1.
Wallace MA. Anatomy and physiology of the kidney. AORN J 1998; 68: 800, 803-16, 819-20.
2.
Dubin RF, Rhee EP. Proteomics and metabolomics in kidney disease, including insights into etiology, treatment, and prevention. Clin J Am Soc Nephrol 2020; 15: 404-11.
3.
Inker LA, Astor BC, Fox CH, et al. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014; 63: 713-35.
4.
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease – a systematic review and meta-analysis. PLoS One 2016; 11: e0158765.
5.
Daley GM, Pretorius CJ, Ungerer JP. Lead toxicity: an Australian perspective. Clin Biochem Rev 2018; 39: 61-98.
6.
Satarug S, Vesey DA, Gobe GC. Current health risk assessment practice for dietary cadmium: data from different countries. Food Chem Toxicol 2017; 106: 430-45.
7.
Satarug S, Gobe GC, Vesey DA, Phelps KR. Cadmium and lead exposure, nephrotoxicity, and mortality. Toxics 2020; 8: 86.
8.
Chen X, Zhu G, Wang Z, et al. The association between lead and cadmium co-exposure and renal dysfunction. Ecotoxicol Environ Safety 2019; 173: 429-35.
9.
Roncal C, Mu W, Reungjui S, et al. Lead, at low levels, accelerates arteriolopathy and tubulointerstitial injury in chronic kidney disease. Am J Physiol Renal Physiol 2007; 293: F1391-6.
10.
Orr SE, Bridges CC. Chronic kidney disease and exposure to nephrotoxic metals. Int J Mol Sci 2017; 18: 1039.
11.
Dewanjee S, Sahu R, Karmakar S, et al. Toxic effects of lead exposure in Wistar rats: involvement of oxidative stress and the beneficial role of edible jute (Corchorus olitorius) leaves. Food Chem Toxicol 2013; 55: 78-91.
12.
Fu S, Zhang L, Ma F, et al. Effects of selenium on chronic kidney disease: a mendelian randomization study. Nutrients 2022; 14: 4458.
13.
Gao P, Tian Y, Xie Q, et al. Manganese exposure induces permeability in renal glomerular endothelial cells via the Smad2/3-Snail-VE-cadherin axis. Toxicol Res 2020; 9: 683-92.
14.
Liu T, Hivert MF, Rifas-Shiman SL, et al. Prospective association between manganese in early pregnancy and the risk of preeclampsia. Epidemiology 2020; 31: 677-80.
15.
Abdel-Moneim AM, El-Toweissy MY, Ali AM, et al. Curcumin ameliorates lead (Pb2+)-induced hemato-biochemical alterations and renal oxidative damage in a rat model. Biol Trace Element Res 2015; 168: 206-20.
16.
Liu G, Wang ZK, Wang ZY, et al. Mitochondrial permeability transition and its regulatory components are implicated in apoptosis of primary cultures of rat proximal tubular cells exposed to lead. Arch Toxicol 2016; 90: 1193-209.
17.
Grau-Perez M, Pichler G, Galan-Chilet I, et al. Urine cadmium levels and albuminuria in a general population from Spain: a gene-environment interaction analysis. Environ Int 2017; 106: 27-36.
18.
Madrigal JM, Ricardo AC, Persky V, et al. Associations between blood cadmium concentration and kidney function in the U.S. population: Impact of sex, diabetes and hypertension. Environ Res 2019; 169: 180-8.
19.
Myong JP, Kim HR, Baker D, et al. Blood cadmium and moderate-to-severe glomerular dysfunction in Korean adults: analysis of KNHANES 2005-2008 data. Int Arch Occup Environ Health 2012; 85: 885-93.
20.
Wu CY, Wong CS, Chung CJ, et al. The association between plasma selenium and chronic kidney disease related to lead, cadmium and arsenic exposure in a Taiwanese population. J Hazard Materials 2019; 375: 224-32.
21.
Buser MC, Ingber SZ, Raines N, et al. Urinary and blood cadmium and lead and kidney function: NHANES 2007-2012. Int J Hyg Environ Health 2016; 219: 261-7.
22.
Navas-Acien A, Tellez-Plaza M, Guallar E, et al. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am J Epidemiol 2009; 170: 1156-64.
23.
Hsueh YM, Huang YL, Lin YF, et al. Plasma vitamin B(12) and folate alter the association of blood lead and cadmium and total urinary arsenic levels with chronic kidney disease in a Taiwanese population. Nutrients 2021; 13: 3841.
24.
Yuebin L, Feng Z, Yidan Q, et al. Association of cadmium internal exposure with chronic kidney disease in Chinese adults. Natl Med J 2021; 101: 1921-8.
25.
Cao C, Fan R, Zhao J, et al. Impact of exudative diathesis induced by selenium deficiency on LncRNAs and their roles in the oxidative reduction process in broiler chick veins. Oncotarget 2017; 8: 20695-705.
26.
Kim NH, Hyun YY, Lee KB, et al. Environmental heavy metal exposure and chronic kidney disease in the general population. J Korean Med Sci 2015; 30: 272-7.
27.
Soderland P, Lovekar S, Weiner DE, et al. Chronic kidney disease associated with environmental toxins and exposures. Adv Chronic Kidney Dis 2010; 17: 254-64.
28.
Prozialeck WC, Edwards JR, Woods JM. The vascular endothelium as a target of cadmium toxicity. Life Sci 2006; 79: 1493-506.
29.
Johri N, Jacquillet G, Unwin R. Heavy metal poisoning: the effects of cadmium on the kidney. Biometals 2010; 23: 783-92.
30.
Matsuda M, Shimomura I. Increased oxidative stress in obesity: implications for metabolic syndrome, diabetes, hypertension, dyslipidemia, atherosclerosis, and cancer. Obes Res Clin Pract 2013; 7: e330-41.
31.
Rhee SY, Hwang YC, Woo JT, et al. Blood lead is significantly associated with metabolic syndrome in Korean adults: an analysis based on the Korea National Health and Nutrition Examination Survey (KNHANES), 2008. Cardiovasc Diabetol 2013; 12: 9.
32.
Jiang F, Zhi X, Xu M, et al. Gender-specific differences of interaction between cadmium exposure and obesity on prediabetes in the NHANES 2007–2012 population. Endocrine 2018; 61: 258-66.
33.
Yoopan N, Watcharasit P, Wongsawatkul O, et al. Attenuation of eNOS expression in cadmium-induced hypertensive rats. Toxicol Lett 2008; 176: 157-61.
34.
Wang Q, Wei S. Cadmium affects blood pressure and negatively interacts with obesity: findings from NHANES 1999–2014. Sci Total Environ 2018; 643: 270-6.
35.
Vaziri ND. Mechanisms of lead-induced hypertension and cardiovascular disease. Am J Physiol Heart Circ Physiol 2008; 295: H454-65.
36.
An HC, Sung JH, Lee J, et al. The association between cadmium and lead exposure and blood pressure among workers of a smelting industry: a cross-sectional study. Ann Occup Environ Med 2017; 29: 47.
37.
Chung S, Chung JH, Kim SJ, et al. Blood lead and cadmium levels and renal function in Korean adults. Clin Exp Nephrol 2014; 18: 726-34.
38.
Jain RB. Co-exposures to toxic metals cadmium, lead, and mercury and their impact on unhealthy kidney function. Environ Sci Pollution Res Int 2019; 26: 30112-8.
Share
RELATED ARTICLE
| eISSN: | 1896-9151 |
| ISSN: | 1734-1922 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
